{"entity":{"id":"crispr-copy-number-artifact","kind":"term","name":"Copy-number artifacts in gene-dependency screens","aka":["CRISPR copy-number effect","gene-independent CRISPR cutting toxicity"],"tldr":"Cutting many copies of a DNA region can slow cell growth even when the named gene is not the cause. Gene-dependency screens need to distinguish this effect from dependence on the gene itself.","summary":"Primary cancer-cell screening experiments showed that CRISPR-Cas9 cutting in amplified regions could cause a gene-independent antiproliferative response. The CERES method subsequently modeled copy-number effects to improve specificity of essentiality estimates. A corrected score still depends on the experiment and algorithm. Guide depletion does not by itself identify a mechanism of cell death or establish that a drug against the nominated protein will help patients.","asOf":"2026-11-08","links":[{"label":"Gene-independent response to CRISPR cutting (2016)","url":"https://doi.org/10.1158/2159-8290.CD-16-0154"},{"label":"CERES correction for copy-number effects (2017)","url":"https://doi.org/10.1038/ng.3984"}],"tags":[],"related":["gene-amplification","on-target-drug-validation"],"cancers":[],"sections":[],"technologies":["crispr-screens"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Methods and models"},"route":"/terms/crispr-copy-number-artifact/","neighbours":{"term":[{"id":"gene-amplification","kind":"term","name":"Gene amplification and copy-number change","route":"/terms/gene-amplification/"},{"id":"on-target-drug-validation","kind":"term","name":"On-target validation of drug effects","route":"/terms/on-target-drug-validation/"}],"technology":[{"id":"crispr-screens","kind":"technology","name":"CRISPR functional genomics","route":"/technologies/crispr-screens/"}]}}